Skip to main content
AOSSM 2026 Annual Meeting Main banner

Concurrent Session III- When the Game Hits the Ground: Sports Foot & Ankle Injuries

Case Presentations and Panel Q&A

Saturday, July 11, 2026
3:04 PM - 3:15 PM PDT
Location: Level 6, Ballroom 6A

    Panel Moderator(s)

  • Michelle Wolcott, MD

    Professor & Vice Chair Academic Engagement
    University of Colorado School of Medicine
    Denver, CO, US

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Concurrent Session Moderator(s)

  • Ned Amendola, MD

    Director of Sports Medicine
    Duke University
    Durham, NC, US

    Disclosure(s): Arc Techtonics: Own stock options in a privately held ineligible company (Ongoing); Arthrex Inc: Consultant (Ongoing), Royalties (Ongoing); Bone Solutions: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing); MIACH: Own stock options in a privately held ineligible company (Ongoing); Rubber City Bracing: Own stock options in a privately held ineligible company (Ongoing); Stryker: Researcher (Ongoing); Vericel: Researcher (Ongoing)

    • Session Panelist(s)

  • Kevin Martin, DO

    Associate Professor
    The Ohio State Wexner Medical Center
    Delaware , OH, US

    Disclosure(s): Arthrex: Consultant (Ongoing); ConMed: Royalties (Ongoing)

  • Brian C. Lau, MD

    Associate Professor
    Duke University

    Disclosure(s): Arthrex: Speaker (Ongoing); Cytek: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing); MIACH: Consultant (Ongoing); Newclip: Consultant (Ongoing), Royalties (Ongoing)

  • C. Thomas Haytmanek, MD

    The Steadman Clinic
    Edwards, CO, US

    Disclosure(s): Arthrex Inc: Consultant (Ongoing); Stryker: Researcher (Ongoing)

Disclosure(s):
Ned Amendola, MD: Arc Techtonics: Own stock options in a privately held ineligible company (Ongoing); Arthrex Inc: Consultant (Ongoing), Royalties (Ongoing); Bone Solutions: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing); MIACH: Own stock options in a privately held ineligible company (Ongoing); Rubber City Bracing: Own stock options in a privately held ineligible company (Ongoing); Stryker: Researcher (Ongoing); Vericel: Researcher (Ongoing)
Kevin Martin, DO: Arthrex: Consultant (Ongoing); ConMed: Royalties (Ongoing)
Brian C. Lau, MD: Arthrex: Speaker (Ongoing); Cytek: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing); MIACH: Consultant (Ongoing); Newclip: Consultant (Ongoing), Royalties (Ongoing)
C. Thomas Haytmanek, MD: Arthrex Inc: Consultant (Ongoing); Stryker: Researcher (Ongoing)